The Corporate and Business Development Finance team partners with the business to support external business development assessments and subsequent post-merger integration, as well as internal portfolio pipeline assessments, through rigorous financial valuation and pro forma financial impact; long term revenue forecasting of internal and external programs; long range planning to ensure delivery of corporate strategic goals; and other corporate-level cross-functional value-creation analyses. This position reports to the Director of Corporate and Business Development Finance.
Analyzes financial feasibility and conducts appropriate due diligence to ensure reliability of information provided by third parties to test and refine assumptions for financial valuation.
Collaborates with other Finance, Research and Development, Commercial, and Business Development stakeholders to develop financial assumptions and analyze valuation, including revenue forecasts and NPV
Assesses financial impact to Alexion for potential new acquisitions and in-licensing opportunities, ensuring alignment with appropriate external and internal benchmarks, and industry best practice
Perform sensitivity and scenario analysis to ask challenging questions to refine assumptions
Supports Long Range Planning, by partnering with internal finance team and business partners to understand the long-term business outlook
Consolidates and analyzes long range planning inputs from the business and distills relevant insights on driving value creation in both the short- and long-term
Performs scenario analyses around Long Range Plan trajectories to ensure delivery of strategic and corporate goals, and communicates analyses to key business partners
Analyzes and evaluates corporate financial decisions, such as capital allocation and investment strategies
6+ years of experience in related field
In-depth Pharmaceutical/Biotechnology industry experience
Bachelor's degree required, MBA highly preferred
Strong business acumen; proven ability to effectively scrutinize and challenge assumptions and interpret the strategy and priorities of the organization
Strong industry acumen to assess and anticipate cross-functional interdependencies, and both strategic and financial implications
Excellent project management and leadership skills with demonstrated track record and ability to engage cross-functional teams to work together on senior level assessments
Strong communication skills to present decision-relevant insights and recommendations and analyses to senior executives
Experienced in collaboration with colleagues (within or outside of finance) in sharing insights and learnings, to challenge status quo to deliver on quality analysis and drive incremental value in a continuous improvement mindset, with flexibility and ability to adapt to change
Ability to plan in the short- and long-term, cross-functionally, and at the higher strategic and detailed level, to consolidate the big picture for the corporation, to anticipate risks and deliver on corporate goals
Empowered ownership mindset, with the willingness to take a project and analysis to completion, while consulting relevant stakeholders, to scope and define problems and execute meaningful solutions
Exceptional attitude, strategic thinking, attention to detail, and ability to motivate others to do the same
Boston, MA, United States
Some opportunities happen only once in a lifetime - like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. As the global leader in complement biology and inhibition for more than 20 years, Alexion has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D). In addition, the company is developing two late-stage therapies, a second complement inhibitor and a copper-binding agent for Wilson disease. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, and metabolic disorders. Alexion has been named to the Forbes list of the World's Most Innovative Companies seven years in a row and is headquartered in Boston, Massachusetts' Innovation District. The company also has offices around the globe and serves patients in more than 50 countries.
Alexion's aspiration is to be the most rewarding place to work, where people are empowered to make a difference and where diversity of backgrounds and ideas is encouraged. We are looking for talented individuals who share our passion and commitment to change the lives of patients with rare diseases. We hope you will consider joining our team. Further information about Alexion can be found at: www.alexion.com.
As a leading employer in our industry, Alexion is proud to offer a highly competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more.
Alexion Pharmaceuticals, Inc.